Development of a hydrogel containing metronidazoleloaded Eudragit RS 100 nanoparticles for buccal drug delivery

Abstract

Purpose: To formulate Eudragit RS 100-based nanoparticles containing metronidazole (MTZ NPs) and incorporate them into hydrogels  using different gelling agents for controlled release in the buccal mucosa. Method: MTZ NPs were fabricated using the nanoprecipitation method. MTZ NPs (1 % w/w) were introduced into hydrogels using  different gelling excipients. Physicochemical properties of MTZ NPs, mucoadhesive strength and spreadability of the hydrogels, and ex  vivo permeation of MTZ were evaluated. Results: MTZ NPs were spherical in shape and had a mean particle size of 201.9 ± 5.6 nm, polydispersity index (PDI) of 0.092 ± 0.014, and  encapsulation efficiency of 46.28 ± 1.18 %. Hydroxyethyl cellulose (HEC) hydrogel containing MTZ NPs showed homogenous and smooth appearance, mucoadhesive strength of 2789.7 ± 13.4 dyne/cm2 , and spreadability of 5.32 ± 0.77 cm. The cumulative amount of drug  permeated from MTZ hydrogel and MTZ-containing NP hydrogel through porcine buccal mucosa was 1104.33 ± 28.97 and 397.62 ± 16.13  µg/cm2 , respectively, after 7 h (p < 0.05). Conclusion: HEC hydrogel containing MTZ NPs demonstrates high mucoadhesive strength,  good spreadability, and sustained ex vivo permeation of MTZ. Thus, HEC hydrogel is a promising pharmaceutical formulation for  controlled drug release in the buccal mucosa